CORE--CLINICAL

核心--临床

基本信息

  • 批准号:
    6932809
  • 负责人:
  • 金额:
    $ 25.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

The principal functions of the Clinical Core of the UCI ADRC are: to recruit, characterize, and longitudinally follow subjects as part of our clinical and neurobiological investigations of aging and Alzheimer's disease, and to provide a resource for all investigators involved in the study of aging and AD at UCI and nationally by providing well-characterized subjects for clinical trials, genetic studies, tissue repositories, and imaging protocols. With this renewal the Clinical Core has responded to the RFA and the needs of our investigators by assembling three cohorts of subjects to examine the cognitive states associated with old age and Down syndrome. Extending our previous cohort of subjects (the Clinical Cohort, N=250), the Core has added two special interest groups of subjects. The 90+ Autopsy Cohort (N=100) provides unique opportunities to better understand the brain/behavior relationships and effects of aging in the most rapidly growing segment of the population, the oldest old. Our center also brings to the ADC system another unique cohort, the adult Down Syndrome Cohort (N=75). These subjects are followed with the same methodology used for all ADRC subjects, and provide opportunities for innovative investigations by our basic and clinical scientists. Brain donation is requested from all ADRC subjects, and is required on enrollment, except for DS subjects (50% autopsy participation) and minorities. We aggressively work to increase autopsy participation in these subjects. The Clinical Core, with expertise in neurology, neuropsychology, and nursing, interacts closely with all ADRC cores, NACC, and local and national researchers. Supporting the ADRC's experimental studies, the Clinical Core provides subjects and clinical data to Project 1, biological tissues and clinical data to Project 2, and human data for comparison studies in the transgenic investigations of Project 3. With our unique subject populations, the ADRC Clinical Core brings to UCI and the ADC system a central resource for innovative studies of aging and AD.
UCI ADRC临床核心的主要功能是:招募,鉴定,和

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLAUDIA H. KAWAS其他文献

CLAUDIA H. KAWAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLAUDIA H. KAWAS', 18)}}的其他基金

Core B-Clinical Core
核心 B-临床核心
  • 批准号:
    9922101
  • 财政年份:
    2020
  • 资助金额:
    $ 25.01万
  • 项目类别:
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
白细胞衍生的生物标志物作为阿尔茨海默病风险和进展的预测因子
  • 批准号:
    8166929
  • 财政年份:
    2009
  • 资助金额:
    $ 25.01万
  • 项目类别:
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
白细胞衍生的生物标志物作为阿尔茨海默病风险和进展的预测因子
  • 批准号:
    7951079
  • 财政年份:
    2008
  • 资助金额:
    $ 25.01万
  • 项目类别:
Core--Clinical
核心--临床
  • 批准号:
    6578726
  • 财政年份:
    2002
  • 资助金额:
    $ 25.01万
  • 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
  • 批准号:
    8230622
  • 财政年份:
    2002
  • 资助金额:
    $ 25.01万
  • 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
  • 批准号:
    7463369
  • 财政年份:
    2002
  • 资助金额:
    $ 25.01万
  • 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
  • 批准号:
    6934497
  • 财政年份:
    2002
  • 资助金额:
    $ 25.01万
  • 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
  • 批准号:
    6907727
  • 财政年份:
    2002
  • 资助金额:
    $ 25.01万
  • 项目类别:
Core--Education and information transfer
核心--教育与信息传递
  • 批准号:
    6578728
  • 财政年份:
    2002
  • 资助金额:
    $ 25.01万
  • 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
  • 批准号:
    7496763
  • 财政年份:
    2002
  • 资助金额:
    $ 25.01万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 25.01万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 25.01万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 25.01万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 25.01万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 25.01万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 25.01万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 25.01万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 25.01万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 25.01万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 25.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了